Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-05

Clinical Trial Update: Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing induction chemotherapy followed by cetuximab plus radiotherapy versus radiotherapy with cisplatin for head and neck cancer is in status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Cetuximab (cetuximab)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: UNKNOWN